APA

Ruel R., Thibeault C., L'Heureux A., Martel A., Cai Z., Wei D., Qian L., Barrish J. C., Mathur A., D'Arienzo C., Hunt J. T., Kamath A., Marathe P., Zhang Y., Derbin G., Wautlet B., Mortillo S., Jeyaseelan R., Henley B., Tejwani R., Bhide R. S., Trainor G. L., Fargnoli J. & Lombardo L. J. (20080715). Discovery and preclinical studies of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo active potent VEGFR-2 inhibitor. : Bioorganic & medicinal chemistry letters.

Chicago

Ruel Réjean, Thibeault Carl, L'Heureux Alexandre, Martel Alain, Cai Zhen-Wei, Wei Donna, Qian Ligang, Barrish Joel C, Mathur Arvind, D'Arienzo Celia, Hunt John T, Kamath Amrita, Marathe Punit, Zhang Yueping, Derbin George, Wautlet Barri, Mortillo Steven, Jeyaseelan Robert, Henley Benjamin, Tejwani Ravindra, Bhide Rajeev S, Trainor George L, Fargnoli Joseph and Lombardo Louis J. 20080715. Discovery and preclinical studies of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo active potent VEGFR-2 inhibitor. : Bioorganic & medicinal chemistry letters.

Harvard

Ruel R., Thibeault C., L'Heureux A., Martel A., Cai Z., Wei D., Qian L., Barrish J. C., Mathur A., D'Arienzo C., Hunt J. T., Kamath A., Marathe P., Zhang Y., Derbin G., Wautlet B., Mortillo S., Jeyaseelan R., Henley B., Tejwani R., Bhide R. S., Trainor G. L., Fargnoli J. and Lombardo L. J. (20080715). Discovery and preclinical studies of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo active potent VEGFR-2 inhibitor. : Bioorganic & medicinal chemistry letters.

MLA

Ruel Réjean, Thibeault Carl, L'Heureux Alexandre, Martel Alain, Cai Zhen-Wei, Wei Donna, Qian Ligang, Barrish Joel C, Mathur Arvind, D'Arienzo Celia, Hunt John T, Kamath Amrita, Marathe Punit, Zhang Yueping, Derbin George, Wautlet Barri, Mortillo Steven, Jeyaseelan Robert, Henley Benjamin, Tejwani Ravindra, Bhide Rajeev S, Trainor George L, Fargnoli Joseph and Lombardo Louis J. Discovery and preclinical studies of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo active potent VEGFR-2 inhibitor. : Bioorganic & medicinal chemistry letters. 20080715.